Clinical significance of PDEF factor expression and its relation to androgen receptor in ER−breast cancer-Reference-Cited by-同舟云学术

Clinical significance of PDEF factor expression and its relation to androgen receptor in ER−breast cancer

Published:2018-08-23 Issue:5 Volume:73 Page:819-831
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Cao Lu¹,Li Congying¹,Xu Cong¹,Xiang Guomin¹,Liu Fang¹,Liu Xiaozhen¹,Jiao Jiao¹,Lv Shuhua²,Niu Yun¹^ORCID

Affiliation:

1. Department of Breast Cancer Pathology and Research Laboratory; Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy; Tianjin's Clinical Research Center for Cancer; Tianjin Medical University; Ministry of Education; Tianjin China

2. Department of Pathology; Tianjin Union Medical Center; Tianjin People's Hospital; Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.13699/fullpdf

Reference28 articles.

1. Implementing neoadjuvant endocrine strategies in er-positive, HER2-negative breast cancer;Matikas;Exp. Rev. Anticancer Ther.,2017

2. A review of an unfavorable subset of breast cancer: estrogen receptor positive progesterone receptor negative;Thakkar;Oncologist,2011